BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33974057)

  • 1. Assessment of Primary Care Appointment Times and Appropriate Prescribing of Statins for At-Risk Patients.
    Hare AJ; Adusumalli S; Park S; Patel MS
    JAMA Netw Open; 2021 May; 4(5):e219050. PubMed ID: 33974057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing Statins to Reduce Cardiovascular Disease: 10 Common Misconceptions.
    Schade DS; Shey L; Eaton RP
    Am J Med; 2019 Aug; 132(8):897-899. PubMed ID: 30851261
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescribing statins in general practice: who decides?
    Steel N; Fleetcroft B; Hassan Y
    Br J Gen Pract; 2017 Jun; 67(659):246-247. PubMed ID: 28546390
    [No Abstract]   [Full Text] [Related]  

  • 4. Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk.
    Schilling C; Knight J; Mortimer D; Petrie D; Clarke P; Chalmers J; Kerr A; Jackson R
    Health Policy; 2017 Dec; 121(12):1233-1239. PubMed ID: 29042060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An observational study of how clinicians use cardiovascular risk assessment to inform statin prescribing decisions.
    Robinson T; Jackson R; Wells S; Kerr A; Marshall R
    N Z Med J; 2017 Oct; 130(1463):28-38. PubMed ID: 28981492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Statins: from data to routine prescription…].
    Vital Durand D
    Rev Med Interne; 2014 Mar; 35(3):151-3. PubMed ID: 24314846
    [No Abstract]   [Full Text] [Related]  

  • 7. Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis.
    Fleetcroft R; Schofield P; Ashworth M
    BMC Health Serv Res; 2014 Sep; 14():414. PubMed ID: 25240604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study.
    Son KB; Bae S
    BMJ Open; 2019 Mar; 9(3):e026603. PubMed ID: 30842117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between frequency of primary care provider visits and evidence-based statin prescribing and statin adherence: Findings from the Veterans Affairs system.
    Ahmed ST; Mahtta D; Rehman H; Akeroyd J; Al Rifai M; Rodriguez F; Jneid H; Nasir K; Samad Z; Alam M; Petersen LA; Virani SS
    Am Heart J; 2020 Mar; 221():9-18. PubMed ID: 31896038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key factors influencing the prescribing of statins: a qualitative study among physicians working in primary healthcare facilities in Indonesia.
    Irawati S; Prayudeni S; Rachmawati R; Wita IW; Willfert B; Hak E; Taxis K
    BMJ Open; 2020 Jun; 10(6):e035098. PubMed ID: 32540888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing cardiovascular risk factors: the gap between evidence and practice.
    Turnbull F
    PLoS Med; 2005 May; 2(5):e131. PubMed ID: 15916459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based prescribing: combining network meta-analysis with multicriteria decision analysis to choose among multiple drugs.
    Naci H; van Valkenhoef G; Higgins JP; Fleurence R; Ades AE
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):787-92. PubMed ID: 25097214
    [No Abstract]   [Full Text] [Related]  

  • 13. Statins for secondary cardiovascular disease prevention for older primary care patients.
    Niska R; Han B
    J Natl Med Assoc; 2009 Jul; 101(7):705-10. PubMed ID: 19634592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why are statin prescribing guidelines for primary prevention not always followed in primary care?
    Hassan Y; Ford J; Steel N; Sheldon J; Fleetcroft R
    Br J Gen Pract; 2016 Oct; 66(651):536-7. PubMed ID: 27688515
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimal Prescribing of Statins to Reduce Cardiovascular Disease.
    Schade DS; Duro T; Eaton RP
    Am J Med; 2023 Dec; 136(12):1133-1135. PubMed ID: 37572739
    [No Abstract]   [Full Text] [Related]  

  • 16. All people over 75 years with a five-year CVD risk of ≥15% should be treated with statins unless specifically contraindicated: no.
    Mangin D
    J Prim Health Care; 2010 Dec; 2(4):333-5. PubMed ID: 21125076
    [No Abstract]   [Full Text] [Related]  

  • 17. Opportunities for deprescribing statins in patients with poor cancer prognosis.
    Turner J; Singhal N; Bell JS
    J Palliat Med; 2013 Nov; 16(11):1328. PubMed ID: 24053634
    [No Abstract]   [Full Text] [Related]  

  • 18. Audit-based education to reduce suboptimal management of cholesterol in primary care: a before and after study.
    de Lusignan S; Belsey J; Hague N; Dhoul N; van Vlymen J
    J Public Health (Oxf); 2006 Dec; 28(4):361-9. PubMed ID: 17038329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Starting statins for primary prevention of cardiovascular disease.
    Tunstall-Pedoe H
    Heart; 2013 Nov; 99(21):1547-8. PubMed ID: 23878178
    [No Abstract]   [Full Text] [Related]  

  • 20. Miracle or mirage?
    Learner S
    Nurs Stand; 2007 Aug 1-7; 21(47):18-20. PubMed ID: 17824448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.